On Feb. 21, 2022, China NMPA issued the Management of Cosmetic Adverse Reaction Monitoring, which is China’s first regulation specifically for the management of cosmetic adverse reaction monitoring.
Following the first public consultation on Sept. 28, 2020, and the second public consultation on Sept. 29, 2021, China National Medical Products Administration (NMPA) released the finalized Measures for the Management of Cosmetic Adverse Reaction Monitoring (the Measures) on Feb. 21, 2022, which will take effect on Oct. 1, 2022. 1
We provide full-scale global cosmetic market entry services (including cosmetic registering & filing, regulatory consultation, customized training, market research, branding strategy). Please contact us to discuss how we can help you by cosmetic@chemlinked.com
CSAR Subsidiary Regulations: Draft Regulations on Cosmetic Adverse Reaction Monitoring Unveiled
CSAR Subsidiary Regulations: China Starts a New Round of Consultation on Regulations for Cosmetic Adverse Reaction Monitoring
Indonesia Implements Regulations for Cosmetics GMP and Adverse Reaction Monitoring
